Cancer Letters
Volume 224, Issue 1 , Pages 105-109 , 16 June 2005

PTEN and Egr-1 expression in thyroid proliferative lesions

  • Carla Di Loreto

      Affiliations

    • Anatomic Pathology, University of Udine, Udine, Italy
    • ,
  • Gianluca Tell

      Affiliations

    • Department of Biomedical Sciences and Technologies, University of Udine, Udine, Italy
    • ,
  • Marta Pestrin

      Affiliations

    • Clinical Oncology, University of Udine, Udine, Italy
    • ,
  • Maura Pandolfi

      Affiliations

    • Anatomic Pathology, University of Udine, Udine, Italy
    • ,
  • Giuseppe Damante

      Affiliations

    • Genetics, University of Udine, Udine, Italy
    • ,
  • Fabio Puglisi

      Affiliations

    • Clinical Oncology, University of Udine, Udine, Italy
    • Corresponding Author InformationCorresponding author. Address: Clinica Oncologica, Policlinico Universitario, Piazzale SM Misericordia, I-33100, Udine, Italy. Tel.: +39 432 559304; fax: +39 432 559305.

Received 29 July 2004 ,Revised 28 September 2004 ,Accepted 1 October 2004.

References 

  1. Gimm O. Thyroid cancer. Cancer Lett. 2001;163:143–156
  2. Liaw D, Marsh DJ, Li J, Dahia PL, Wang SI, Zheng Z, et al. Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome. Nat. Genet. 1997;16:64–67
  3. Li DM, Sun H. TEP 1, encoded by a candidate tumor suppressor locus, is a novel protein tyrosin phosphatase regulated by trasforming growth factor beta. Cancer Res. 1997;57:2124–2129
  4. Li J, Yen C, Liaw D, Podsypanina K, Bose S, Wang SI, et al. PTEN, a putative protein tyrosine phosphatase gene mutated in human brain, breast and prostate cancer. Science. 1997;275:1943–1947
  5. Steck PA, Pershouse MA, Jasser SA, Yung WK, Lin H, Ligon AH, et al. Identification of a candidate tumor suppressor gene, MMCA1, at chromosome 10q23.3 that is mutated in multiple advanced cancer. Nat. Genet. 1997;15:356–362
  6. Di Cristofano A, Pandolfi PP. The multiple roles of PTEN in tumor suppression. Cell. 2000;100:387–390
  7. Myers MP, Pass I, Batty IH, Van der Kaay J, Stolarov JP, Hemmings BA, et al. The lipid phosphatase activity of PTEN is critical for its tumor suppressor function. Proc. Natl Acad. Sci. USA. 1998;95:13513–13518
  8. Maehama T, Dixon JE. The tumor suppressor gene PTEN/MMCA1, dephosphorylates lipid second messenger, phosphatidylinositol 3,4,5-triphosphate. J. Biol. Chem. 1998;273:13375–13378
  9. Furnari FB, Huang HJ, Cavence WK. The phosphoinositol phosphate activity of PTEN mediates a serum-sensitive G1 growth arrest in glioma cells. Cancer Res. 1998;58:1633–1639
  10. Stambolic V, Suzuki A, de la Pompa JL, Brothers GM, Mirtsos C, Sasaki T, et al. Negative regulation of PKB/Akt-dependent cell survival by the tumor suppressor PTEN. Cell. 1998;95:29–39
  11. Weng LP, Gimm O, Kum JB, Smith WM, Zhou XP, Wynford-Thomas D, et al. Transient ectopic expression of PTEN in thyroid cancer cell lines induces cell cycle arrest and cell type-dependent cell death. Human Mol. Genet. 2001;10:251–258
  12. Dahia PL, Marsh DJ, Zheng Z, Zedenius J, Komminoth P, Frisk T, et al. Somatic deletions and mutations in the Codwen disease gene, PTEN, in sporadic thyroid tumors. Cancer Res. 1997;57:4710–4713
  13. Dahia PL, FitzGerald MG, Zhang X, Marsh DJ, Zheng Z, Pietsch T, et al. A highly conserved processed PTEN pseudogene is located on chromosome band 9p21. Oncogene. 1998;16:2403–2406
  14. Gimm O, Attie-Bitach T, Lees JA, Vekemans M, Eng C. Expression of the PTEN tumor suppressor protein during human development. Hum. Mol. Genet. 2000;9:1633–1639
  15. Halachmi N, Halachmi S, Evron E, Cairns P, Okami K, Saji M, et al. Somatic mutations of the PTEN tumor suppressor gene in sporadic follicular thyroid tumors. Genes Chromosome Cancer. 1998;23:239–243
  16. Mitchell A, Dass CR, Sun LQ, Khachigian LM. Inhibition of human breast carcinoma proliferation, migration, chemoinvasion and solid tumour growth by DNAzymes targeting the zinc finger transcription factor EGR-1. Nucleic Acid Res. 2004;32:3065–3069
  17. Virolle T, Adamson ED, Baron V, Birle D, Mercola D, Mustelin T, et al. The Egr-1 trascription factor directly activates PTEN during irradiation-induced signalling. Nat. Cell Biol. 2001;3:1124–1128
  18. Gimm O, Perren A, Weng LP, Marsh DJ, Yeh JJ, Ziebold U, et al. Differential nuclear and cytoplasmic expression of PTEN in normal thyroid tissue, and benign and malignant epithelial thyroid tumors. Am. J. Pathol. 2000;156:693–1700
  19. Bruni P, Boccia A, Baldassarre G, Trapasso F, Santoro M, Chiappetta G, et al. PTEN expression is reduced in a subset of sporadic thyroid carcinomas: evidence that PTEN-growth suppressing activity in thyroid cancer cells mediated by p27kip1. Oncogene. 2000;19:3146–3155
  20. Frisk T, Foukakis T, Dwight T, Lundberg J, Hoog A, Wallin G, et al. Silencing of the PTEN tumor-suppressor gene in anaplastic thyroid cancer. Genes Chromosome Cancer. 2002;35:74–80
  21. Maenhaut C, Roger PP, Reuse S, Dumont JE. Activation of the cyclic AMP cascade as an oncogenic mechanism: the thyroid example. Biochimie. 1991;73:29–36
  22. Deleu S, Allory Y, Radulescu A, Pirson I, Carrasco N, Corvilain B, et al. Characterization of autonomous thyroid adenoma: metabolism, gene expression, and pathology. Thyroid. 2000;10:131–138
  23. Schlumberger MJ. Papillary and follicular thyroid carcinoma. N. Engl. J. Med. 1998;338:297–306

PII: S0304-3835(04)00778-5

doi: 10.1016/j.canlet.2004.10.014

Cancer Letters
Volume 224, Issue 1 , Pages 105-109 , 16 June 2005

Article Tools

* Image Usage & Resolution